6 Treffer
ID | Publikation | |
---|---|---|
21185 | Adam, I., Dewi, D.L., Mooiweer, J., Sadik, A., Mohapatra, S.R., Berdel, B., Keil, M., Sonner, J.K., Thedieck, K., Rose, A.J., Platten, M., Heiland, I., Trump, S., Opitz, C.A. (2018): Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation Oncoimmunology 7 (12), e1486353 Volltext (DOI) |
|
18223 | Dewi, D.L., Mohapatra, S.R., Cabañes, S.B., Adam, I., Patterson, L.F.S., Berdel, B., Kahloon, M., Thürmann, L., Loth, S., Heilmann, K., Weichenhan, D., Mücke, O., Heiland, I., Wimberger, P., Kuhlmann, J.D., Kellner, K.-H., Schott, S., Plass, C., Platten, M., Gerhäuser, C., Trump, S., Opitz, C.A. (2017): Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer Oncoimmunology 6 (2), e1274477 Volltext (DOI) |
|
18890 | Dewi, D.L., Mohapatra, S., Wimberger, P., Kuhlmann, J.D., Schott, S., Kellner, K.-H., Gerhauser, C., Trump, S., Opitz, C.A. (2017): Epigenetic regulation of indoleamine-2,3-dioxygenase 1 expression in human breast cancer Breast 32 (Suppl. 1), S31 - S32 Volltext (DOI) |
|
14754 | Litzenburger, U.M., Opitz, C.A., Sahm, F., Rauschenbach, K.J., Trump, S., Winter, M., Ott, M., Ochs, K., Lutz, C., Liu, X., Anastasov, N., Lehmann, I., Höfer, T., von Deimling, A., Wick, W., Platten, M. (2014): Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR Oncotarget 5 (4), 1038 - 1051 Volltext (DOI) |
|
11625 | Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., Jugold, M., Guillemin, G.J., Miller, C.L., Lutz, C., Radlwimmer, B., Lehmann, I., von Deimling, A., Wick, W., Platten, M. (2011): An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 (7368), 197 - 203 Volltext (DOI) |
|
23546 | Sadik, A., Somarribas Patterson, L.F., Öztürk, S., Mohapatra, S.R., Panitz, V., Secker, P.F., Pfänder, P., Loth, S., Salem, H., Prentzell, M.T., Berdel, B., Iskar, M., Faessler, E., Reuter, F., Kirst, I., Kalter, V., Foerster, K.I., Jäger, E., Ramallo Guevara, C., Sobeh, M., Hielscher, T., Poschet, G., Reinhardt, A., Hassel, J.C., Zapatka, M., Hahn, U., von Deimling, A., Hopf, C., Schlichting, R., Escher, B.I., Burhenne, J., Haefeli, W.E., Ishaque, N., Böhme, A., Schäuble, S., Thedieck, K., Trump, S., Seiffert, M., Opitz, C.A. (2020): IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression Cell 182 (5), 1252 - 1270.e34 Volltext (DOI) |